Nobuhiro Moro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nobuhiro Moro has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Yoichi Katayama
Department of Neurological SurgeryNihon University School of Medicine, Tokyo, Japan
4 shared publicationsJun Kojima
Department of Neurological SurgeryNihon University School of Medicine, Tokyo, Japan
3 shared publicationsTatsuro Kawamata
2 shared publicationsTatsuro Mori
2 shared publicationsHideki Oshima
Department of Neurological Surgery, Nihon University School of Medicine
1 shared publicationTakahiro Igarashi
1 shared publication
Latest Publications
- 1 December 2012
- Published by Taylor & Francis in Neurological Research
- Vol. 34 (10) , 1016-1019
Is the circulating plasma volume sufficiently maintained? Fluid management of an aneurysmal subarachnoid hemorrhage in the acute phase
Cerebral vasospasm is a well-known cause of mortality and morbidity following aneurysmal subarachnoid hemorrhage (SAH). Prevention of symptomatic cerebral vasospasm is the basic management after SAH. Numerous pharmaceutical therapies and endovascular treatments are available against cerebral vasospasm, but none of them have so far proven to improve the outcome. We have focused on maintaining the circulation volume in order to prevent cerebral vasospasm. But to maintain the central venous pressure, huge infusion volume was required, and hyponatremia was frequently observed due to natriuresis and osmotic diuresis. Excessive natriuresis and diuresis cannot be managed through sodium and water replacement, since sodium replacement induces further natriuresis and diuresis (desalination), and water replacement induces hyponatremia. We therefore administered fludrocortisone and hydrocortisone to inhibit excessive natriuresis and diuresis. The efficacy of sodium reabsorption therapy is extremely high to maintain the circulation volume that might have a therapeutic effect to prevent cerebral vasospasm. In this article, we review our institution's experience regarding the management of patients with aneurysmal SAH and also discuss the importance of water and sodium balance when managing such patients.
- 1 December 2012
- Published by Taylor & Francis in Neurological Research
- Vol. 34 (10) , 1016-1019
Is the circulating plasma volume sufficiently maintained? Fluid management of an aneurysmal subarachnoid hemorrhage in the acute phase
Cerebral vasospasm is a well-known cause of mortality and morbidity following aneurysmal subarachnoid hemorrhage (SAH). Prevention of symptomatic cerebral vasospasm is the basic management after SAH. Numerous pharmaceutical therapies and endovascular treatments are available against cerebral vasospasm, but none of them have so far proven to improve the outcome. We have focused on maintaining the circulation volume in order to prevent cerebral vasospasm. But to maintain the central venous pressure, huge infusion volume was required, and hyponatremia was frequently observed due to natriuresis and osmotic diuresis. Excessive natriuresis and diuresis cannot be managed through sodium and water replacement, since sodium replacement induces further natriuresis and diuresis (desalination), and water replacement induces hyponatremia. We therefore administered fludrocortisone and hydrocortisone to inhibit excessive natriuresis and diuresis. The efficacy of sodium reabsorption therapy is extremely high to maintain the circulation volume that might have a therapeutic effect to prevent cerebral vasospasm. In this article, we review our institution's experience regarding the management of patients with aneurysmal SAH and also discuss the importance of water and sodium balance when managing such patients.
- 1 October 2007
- Published by Elsevier in Surgical Neurology
- Vol. 68 (4) , 387-393
Hyponatremia in patients with traumatic brain injury: incidence, mechanism, and response to sodium supplementation or retention therapy with hydrocortisone
- 1 October 2007
- Published by Elsevier in Surgical Neurology
- Vol. 68 (4) , 387-393
Hyponatremia in patients with traumatic brain injury: incidence, mechanism, and response to sodium supplementation or retention therapy with hydrocortisone
- 1 January 2005
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 45 (6) , 300-305
Sagittal Magnetic Resonance Imaging of Intramural Hematoma From Non-traumatic Dissection of the Anterior Cerebral Artery-Case Report-
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2005
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 45 (6) , 300-305
Sagittal Magnetic Resonance Imaging of Intramural Hematoma From Non-traumatic Dissection of the Anterior Cerebral Artery-Case Report-
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 December 2003
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (12) , 2807-2811
Prophylactic Management of Excessive Natriuresis With Hydrocortisone for Efficient Hypervolemic Therapy After Subarachnoid Hemorrhage
Background and Purpose— Hyponatremia caused by excessive natriuresis is common in patients with aneurysmal subarachnoid hemorrhage (SAH). Natriuresis decreases the total blood volume through osmotic diuresis and increases the risk of symptomatic cerebral vasospasm. In such patients, hypervolemic therapy is difficult to achieve without causing hyponatremia because sodium replacement provokes further natriuresis and osmotic diuresis. We examined the effects of hydrocortisone, which promotes sodium retention, in patients with SAH. Methods— Twenty-eight SAH patients were randomized into 2 groups after direct surgery: group 1 patients without hydrocortisone treatment (n=14) and group 2 patients with hydrocortisone treatment (1200 mg/d for 10 days; n=14). Both groups underwent hypervolemic therapy by aggressive sodium and water replacement. The goal of the hypervolemic therapy was to maintain the serum sodium level >140 mEq/L and the central venous pressure (CVP) within 8 to 12 cm H 2 O. Results— Group 2 demonstrated a lower sodium excretion ( P P P P P P Conclusions— Hydrocortisone clearly attenuates excessive natriuresis. Prophylactic hydrocortisone administration appears to have a therapeutic value in inducing hypervolemia efficiently after SAH.
- 1 December 2003
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (12) , 2807-2811
Prophylactic Management of Excessive Natriuresis With Hydrocortisone for Efficient Hypervolemic Therapy After Subarachnoid Hemorrhage
Background and Purpose— Hyponatremia caused by excessive natriuresis is common in patients with aneurysmal subarachnoid hemorrhage (SAH). Natriuresis decreases the total blood volume through osmotic diuresis and increases the risk of symptomatic cerebral vasospasm. In such patients, hypervolemic therapy is difficult to achieve without causing hyponatremia because sodium replacement provokes further natriuresis and osmotic diuresis. We examined the effects of hydrocortisone, which promotes sodium retention, in patients with SAH. Methods— Twenty-eight SAH patients were randomized into 2 groups after direct surgery: group 1 patients without hydrocortisone treatment (n=14) and group 2 patients with hydrocortisone treatment (1200 mg/d for 10 days; n=14). Both groups underwent hypervolemic therapy by aggressive sodium and water replacement. The goal of the hypervolemic therapy was to maintain the serum sodium level >140 mEq/L and the central venous pressure (CVP) within 8 to 12 cm H 2 O. Results— Group 2 demonstrated a lower sodium excretion ( P P P P P P Conclusions— Hydrocortisone clearly attenuates excessive natriuresis. Prophylactic hydrocortisone administration appears to have a therapeutic value in inducing hypervolemia efficiently after SAH.